648 related articles for article (PubMed ID: 29545802)
41. CMV induces rapid NK cell maturation in HSCT recipients.
Della Chiesa M; Muccio L; Moretta A
Immunol Lett; 2013; 155(1-2):11-3. PubMed ID: 24076315
[TBL] [Abstract][Full Text] [Related]
42. HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.
Ghobadi A; Milton DR; Gowda L; Rondon G; Chemaly RF; Hamdi A; Alousi A; Afrough A; Oran B; Ciurea S; Kebriaei P; Popat UR; Qazilbash MH; Shpall EJ; Champlin RE; Bashir Q
Curr Res Transl Med; 2019 May; 67(2):51-55. PubMed ID: 30683577
[TBL] [Abstract][Full Text] [Related]
43. Amplified NKG2C+ NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: functional impact in controlling CMV-infected dendritic cells.
Djaoud Z; David G; Bressollette C; Willem C; Rettman P; Gagne K; Legrand N; Mehlal S; Cesbron A; Imbert-Marcille BM; Retière C
J Immunol; 2013 Sep; 191(5):2708-16. PubMed ID: 23918974
[TBL] [Abstract][Full Text] [Related]
44. Naive Donor NK Cell Repertoires Associated with Less Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
Björklund AT; Clancy T; Goodridge JP; Béziat V; Schaffer M; Hovig E; Ljunggren HG; Ljungman PT; Malmberg KJ
J Immunol; 2016 Feb; 196(3):1400-11. PubMed ID: 26746188
[TBL] [Abstract][Full Text] [Related]
45. CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT.
Cichocki F; Cooley S; Davis Z; DeFor TE; Schlums H; Zhang B; Brunstein CG; Blazar BR; Wagner J; Diamond DJ; Verneris MR; Bryceson YT; Weisdorf DJ; Miller JS
Leukemia; 2016 Feb; 30(2):456-63. PubMed ID: 26416461
[TBL] [Abstract][Full Text] [Related]
46. Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on cytomegalovirus reactivation risk after allogeneic hematopoietic stem cell transplantation.
Tassi E; Noviello M; De Simone P; Lupo-Stanghellini MT; Doglio M; Serio F; Abbati D; Beretta V; Valtolina V; Oliveira G; Racca S; Campodonico E; Ruggiero E; Clerici D; Giglio F; Lorentino F; Dvir R; Xue E; Farina F; Oltolini C; Manfredi F; Vago L; Corti C; Bernardi M; Clementi M; Brix L; Ciceri F; Peccatori J; Greco R; Bonini C
Haematologica; 2023 Jun; 108(6):1530-1543. PubMed ID: 36200418
[TBL] [Abstract][Full Text] [Related]
47. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.
Bigley AB; Rezvani K; Shah N; Sekine T; Balneger N; Pistillo M; Agha N; Kunz H; O'Connor DP; Bollard CM; Simpson RJ
Clin Exp Immunol; 2016 Aug; 185(2):239-51. PubMed ID: 26940026
[TBL] [Abstract][Full Text] [Related]
48. CMV-Reactive NK Cells in Pediatric Post-Hematopoietic Stem Cell Transplant.
Apiwattanakul N; Hongeng S; Anurathapan U; Pakakasama S; Srisala S; Klinmalai C; Andersson BS
Transplant Proc; 2020; 52(1):353-359. PubMed ID: 31870602
[TBL] [Abstract][Full Text] [Related]
49. Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCT.
van der Ploeg K; Sottile R; Kontopoulos T; Shaffer BC; Papanicolaou GA; Maloy MA; Cho C; Robinson KS; Perales MA; Le Luduec JB; Hsu KC
Blood Adv; 2023 Oct; 7(19):5784-5798. PubMed ID: 37196646
[TBL] [Abstract][Full Text] [Related]
50. CMV-Specific Immune Response-New Patients, New Insight: Central Role of Specific IgG during Infancy and Long-Lasting Immune Deficiency after Allogenic Stem Cell Transplantation.
Zdziarski P
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641912
[TBL] [Abstract][Full Text] [Related]
51. A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia.
Yang T; Chen ZZ; Kolb HJ; Buhmann R
Immunobiology; 2013 Apr; 218(4):548-53. PubMed ID: 22883564
[TBL] [Abstract][Full Text] [Related]
52. Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation.
Link CS; Eugster A; Heidenreich F; Rücker-Braun E; Schmiedgen M; Oelschlägel U; Kühn D; Dietz S; Fuchs Y; Dahl A; Domingues AM; Klesse C; Schmitz M; Ehninger G; Bornhäuser M; Schetelig J; Bonifacio E
Clin Exp Immunol; 2016 Jun; 184(3):389-402. PubMed ID: 26800118
[TBL] [Abstract][Full Text] [Related]
53. Interferon gamma 13-CA-repeat homozygous genotype and a low proportion of CD4(+) lymphocytes are independent risk factors for cytomegalovirus reactivation with a high number of copies in hematopoietic stem cell transplantation recipients.
Jaskula E; Dlubek D; Duda D; Bogunia-Kubik K; Mlynarczewska A; Lange A
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1296-305. PubMed ID: 19747638
[TBL] [Abstract][Full Text] [Related]
54. Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?
Della Chiesa M; Falco M; Podestà M; Locatelli F; Moretta L; Frassoni F; Moretta A
Blood; 2012 Jan; 119(2):399-410. PubMed ID: 22096237
[TBL] [Abstract][Full Text] [Related]
55. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.
Della Chiesa M; Falco M; Bertaina A; Muccio L; Alicata C; Frassoni F; Locatelli F; Moretta L; Moretta A
J Immunol; 2014 Feb; 192(4):1471-9. PubMed ID: 24442432
[TBL] [Abstract][Full Text] [Related]
56. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
57. Cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem cell transplant correlates with donor killer immunoglobulin-like receptor genotype.
Sobecks RM; Askar M; Thomas D; Rybicki L; Kalaycio M; Dean R; Avery R; Mossad S; Copelan E; Bolwell BJ
Exp Clin Transplant; 2011 Feb; 9(1):7-13. PubMed ID: 21605017
[TBL] [Abstract][Full Text] [Related]
58. Late Development of FcεRγ
Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
Front Immunol; 2018; 9():1050. PubMed ID: 29868012
[TBL] [Abstract][Full Text] [Related]
59. An evaluation of the role of NKG2C+ natural killer cells in protection from cytomegalovirus DNAemia early following allogeneic stem cell transplantation.
Muñoz-Cobo B; Giménez E; Solano C; de la Cámara R; Nieto J; López J; Amat P; Garcia-Noblejas A; Navarro D
J Med Virol; 2014 May; 86(5):806-11. PubMed ID: 24105728
[TBL] [Abstract][Full Text] [Related]
60. Cytomegalovirus-Infected Primary Endothelial Cells Trigger NKG2C+ Natural Killer Cells.
Djaoud Z; Riou R; Gavlovsky PJ; Mehlal S; Bressollette C; Gérard N; Gagne K; Charreau B; Retière C
J Innate Immun; 2016; 8(4):374-85. PubMed ID: 27116381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
